论文部分内容阅读
征集315例健康妇女,将其分成A、B两组,A组房事后72h内单次口服米非司酮150mg;B组:25mg。结果A、B两组实际妊娠率分别为2.48%、1.82%,两组间无显著差异,与预期妊娠率(12.19%、11.71%)相比有显著差异。服药后第一次月经,在卵泡期服药者月经周期延长,A组,33.9%,B组;26.9%。黄体期服药者月经周期准时或提早,A组:71.2%,B组:77.1%,两组之间无差别。A、B两组月经量正常者分别为81%、93%,经期均无改变,显示了米非司酮作为事后避孕药对月经无明显影响。可选择小剂量25mg作为事后避孕药。
315 healthy women were enrolled and divided into A and B groups. Group A received 150 mg of mifepristone once within 72 hours after taking the medicine. Group B: 25 mg. Results The actual pregnancy rates in groups A and B were 2.48% and 1.82%, respectively. There was no significant difference between the two groups, which was significantly different from the expected pregnancy rate (12.19% and 11.71%). After taking the first menstruation, the menstrual cycle in the follicular period was extended, A group, 33.9%, B group; 26.9%. Periodontal administration of luteal phase medication on time or earlier, A group: 71.2%, B group: 77.1%, no difference between the two groups. A, B, two groups were normal menstrual flow were 81%, 93%, menstrual did not change, showing that mifepristone as an after-treatment contraceptives had no significant effect on menstruation. Can choose a small dose of 25mg as a contraceptive pill.